Advances in Dermatology

Each year, the NYU Post-Graduate Medical School and the Ronald O. Perelman Department of Dermatology are proud to host Advances in Dermatology, a symposium which targets practitioners caring for people with skin disease, including dermatologists, dermatologic surgeons, and residents in dermatology.

The 2020 symposium is on Friday, June 5. Learn more the 40th Annual Advances in Dermatology virtual webinar.

Dermatology is a rapidly evolving specialty, with new advances in medical, surgical and cosmetic dermatology made every year. New medications and treatment modalities for both common and uncommon dermatological diseases have been released, or will be in the next few years, that will change the treatment indications for these conditions. In addition, older medications may still play a role in treating these conditions, and how they should be properly incorporated is vital for optimizing patient outcomes.
This two-day program will educate practitioners with an interest in the care of persons with skin disorders, including dermatologists, dermatologic surgeons, other specialists, primary care physicians and residents in dermatology with current therapeutic options and treatment guidelines as taught by an experienced faculty. It will focus on newly emerging clinically applicable knowledge — ranging from new guidelines to recognition of emerging agents and adverse events to translational research — regarding the best approaches to management of patients in order to achieve the best quality of care/ outcomes for patients suffering from both common and uncommon dermatologic conditions.

Learning objectives include:

  • Establish an algorithm to determine which patients with psoriasis or autoimmune dermatological conditions are eligible for each new drug, how to dose the drug and how to safely monitor these patients
  • Better counsel patients on the expected benefits and possible side effects of systemic and topical medications, as well as the use of surgical and other procedural techniques to treat skin diseases and cosmetic concerns
  • Recognize those patients previously ineligible for treatment of acne, rosacea and atopic dermatitis and offer them new therapies
  • Describe the safety profile, risks and side effects of new medications; explain how to dose and monitor therapy; and assess their efficacy depending on the severity of disease
  • Establish a strategy to recognize which patients would benefit from new laser/light source devices or injectable substances, as well as describe how to use them safely and effectively
  • Describe the new indications for management of cutaneous malignancies and outline the opinions for their patients suffering from cutaneous malignancy in order to optimize their outcome